相关实验视频
Updated: Jun 27, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
在2型糖尿病中增加药物使用和多药:从2000年到2020年的丹麦经验
Karl Sebastian Johansson1, Espen Jimenez-Solem1,2,3, Tonny Studsgaard Petersen1,2
1Copenhagen University Hospital, Bispebjerg and Frederiksberg, Department of Clinical Pharmacology, Copenhagen, Denmark.
Diabetes care
|May 6, 2024
概括
在2型糖尿病患者中,药物使用和多种药物的使用显著增加. 这一趋势凸显出医疗保健提供者越来越需要管理与多种药物相关的潜在风险.
科学领域:
- 临床药房 临床药房
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 2型糖尿病经常与其他可治疗的疾病同时发生.
- 多药性,即使用多种药物,是慢性疾病管理中日益关注的问题.
研究的目的:
- 调查2000年至2020年2型糖尿病患者中多药药的趋势.
- 分析药物使用的变化和多药在这个人群中的流行情况.
主要方法:
- 利用丹麦国家登记处建立2000年至2020年2型糖尿病 (年龄≥18) 个体队列.
- 分析了药物使用情况,按年龄,性别,慢性疾病数量和社会经济地位分层.
- 多药学定义为使用≥5或≥10种药物.
主要成果:
- 队列显著扩大,从2000年的84,917名患者增加到2020年的307,011名患者.
- 每名患者平均每日服用的药物从3.7增加到5.3.
- 多种药物的终身风险很高:89%使用≥5种药物,47%使用≥10种药物. 增加是由止痛药,抗高血压药,PPI和他类药物推动的.
结论:
- 药物使用和多药在2型糖尿病患者中明显增加.
- 这种增长需要医疗保健专业人员对多药房风险提高认识.
- 潜在的风险包括药物相互作用,不良反应和处方错误,需要谨慎管理.
相关概念视频
Diabetes: Management and Pharmacotherapy
266
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
266
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Insulin: Dosing Regimen and Adverse Effects
167
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
167
Carbohydrate Metabolism
11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
126
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
126

